Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

KalVista Pharmaceuticals (KALV) Asset Utilization Ratio (2017 - 2021)

KalVista Pharmaceuticals' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.05 for Q1 2021.

  • For Q1 2021, Asset Utilization Ratio fell 50.78% year-over-year to 0.05; the TTM value through Jan 2021 reached 0.05, down 50.78%, while the annual FY2020 figure was 0.12, 32.94% down from the prior year.
  • Asset Utilization Ratio for Q1 2021 was 0.05 at KalVista Pharmaceuticals, down from 0.07 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.2 in Q3 2018 and bottomed at 0.02 in Q3 2017.
  • The 5-year median for Asset Utilization Ratio is 0.12 (2019), against an average of 0.11.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 903.97% in 2018 before it tumbled 50.78% in 2021.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.05 in 2017, then skyrocketed by 258.26% to 0.17 in 2018, then fell by 29.83% to 0.12 in 2019, then plummeted by 44.26% to 0.07 in 2020, then dropped by 20.35% to 0.05 in 2021.
  • Per Business Quant, the three most recent readings for KALV's Asset Utilization Ratio are 0.05 (Q1 2021), 0.07 (Q4 2020), and 0.11 (Q3 2020).